Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Jun Yang, PhD, Heng Xu, PhD, Cheng Cheng, Ph.D., Meenakshi Devidas, PhD, Deqing Pei, Yiping Fan, PhD, Wenjian Yang, PhD, Geoffrey A. Neale, PhD, Naomi J. Winick, MD, Paul L Martin, MD, PhD, Cheryl L. Willman, MD, Bruce M. Camitta, MD, Gregory H. Reaman, PhD, William L. Carroll, PhD, Mignon Loh, MD, Stephen P. Hunger, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2010) 116 (21): 8.

https://doi.org/10.1182/blood.V116.21.8.8

Published: 2010

Journal Articles

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Blaine W. Robinson, PhD, Meenakshi Devidas, PhD, Andrew J. Carroll, PhD, Richard C. Harvey, PhD, Nyla A. Heerema, PhD, Cheryl L. Willman, MD, Amanda R. Hudome, Elliot C. Woods, Nancy C. Ballantyne, Gregory H. Reaman, MD, Joanne M. Hilden, MD, Bruce M. Camitta, MD, Naomi J. Winick, MD, William L. Carroll, MD, Stephen P Hunger, MD, Zoann E. Dreyer, MD, Carolyn A. Felix, MD

Blood (2009) 114 (22): 907.

https://doi.org/10.1182/blood.V114.22.907.907

Published: 2009

Journal Articles

Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).

Naomi Winick, MD, Paul L. Martin, MD, PhD, Meenakshi Devidas, PhD, Jonathan Shuster, PhD, Michael J. Borowitz, MD, PhD, Paul Bowman, MD, Eric Larsen, MD, Jeanette Pullen, MD, Stephen P. Hunger, MD, William L. Carroll, MD, Bruce M. Camitta, MD

Blood (2007) 110 (11): 583.

https://doi.org/10.1182/blood.V110.11.583.583

Published: 2007

Journal Articles

Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).

Thaddeus Y. Carson, BSE, Beverly A. Bell, MD, Gary Erdmann, PhD, Bruce Bostrom, MD, Bruce M. Camitta, MD, Meenakshi Devidas, PhD

Blood (2007) 110 (11): 851.

https://doi.org/10.1182/blood.V110.11.851.851

Published: 2007

Journal Articles

A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.

Beverly A. Bell, MD, Sharon B. Abish, MD, Allen Chauvenet, MD, Joanne Kurtzberg, MD, Jeanette Pullen, MD, Meenakshi Devidas, PhD, Jonathan Shuster, PhD, Bruce M. Camitta, MD

Blood (2005) 106 (11): 875.

https://doi.org/10.1182/blood.V106.11.875.875

Published: 2005

Journal Articles

Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406.

Megan A. Rice, Beverly A. Bell, MD, Allen Chauvenet, MD, Joanne Kurtzberg, MD, Sharon B. Abish, MD, Jeanette Pullen, MD, Meenakshi Devidas, PhD, Bruce M. Camitta, MD

Blood (2005) 106 (11): 880.

https://doi.org/10.1182/blood.V106.11.880.880

Published: 2005

Journal Articles

A Report of the Event-Free Survival (EFS) and Neurotoxicity for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) on Pediatric Oncology Group (POG) Protocol 9405.

Stephen Rodes, BS, Beverly A. Bell, MD, Sharon B. Abish, MD, Jeanette Pullen, MD, Allen Chauvenet, MD, Joanne Kurtzberg, MD, Meenakshi Devidas, PhD, Jonathan Shuster, PhD, Bruce M. Camitta, MD

Blood (2005) 106 (11): 882.

https://doi.org/10.1182/blood.V106.11.882.882

Published: 2005

Journal Articles

Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG).

Kirk R. Schultz, MD, Jeanette Pullen, MD, Harland Sather, PhD, Jonathan Shuster, PhD, Michael J. Borowitz, MD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Paul S. Gaynon, MD, Bruce M. Camitta, MD

Blood (2004) 104 (11): 519.

https://doi.org/10.1182/blood.V104.11.519.519

Published: 2004

NARROW

ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Specific MLL Partner Genes in Infant Acute Lymphoblastic Leukemia (ALL) Associated with Outcome Are Linked to Age and White Blood Cell Count (WBC) at Diagnosis: A Report On the Children's Oncology Group (COG) P9407 Trial.

Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).

Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).

A Report of the Event Free Survival (EFS) for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) Treated on Pediatric Oncology Group (POG) Protocol 9605.

Thrombotic and Hemorrhagic Events for Patients on Pediatric Oncology Group (POG) Protocols 9201, 9605, 9406.

A Report of the Event-Free Survival (EFS) and Neurotoxicity for Children with Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia (ALL) on Pediatric Oncology Group (POG) Protocol 9405.

Biology-Driven Classification of Childhood Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only